Citations

1 Substance Abuse and Mental Health Services Administration, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014. Retrieved from http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/...

2 Warner, M., Chen, L. H., Makuc, D. M., Anderson, R. N., & Minino, A. M. (2011). Drug poisoning deaths in the United States, 1980–2008. NCHS Data Brief (81), 1–8.

3 Morbidity and Mortality Weekly Report. (2011). Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. Morbidity and Mortality Weekly Report, 60(43), 1487–1492.

4 Manchikanti, L., Abdi, S., Atluri, S., Balog, C. C., Benyamin, R. M., Boswell, M. V., . . . & Wargo, B. W. (2012). American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I—Evidence assessment. Pain Physician, 15(3 Suppl), S1–S65.

5 Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (February 22, 2013). The DAWN Report: Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. Rockville, MD.

6 Morbidity and Mortality Weekly Report. (2010). Emergency department visits involving nonmedical use of selected prescription drugs—United States, 2004–2008. Morbidity and Mortality Weekly Report, 59(23), 705–709.

7 NCHS. Multiple cause-of-death data, 1999–2012. CDC WONDER online database. 2014.

8 Warner, M., Hedegaard, H., and Chen, L-H. 2014. "Office of Analysis and Epidemiology Trends in Drug-Poisoning Deaths Involving Opioid Analgesics and Heroin: United States, 1999–2012." National Center for Health Statistics Health E-Stat.

9 Substance Abuse and Mental Health Services Administration, National Survey on Drug Use and Health: Comparison of 2011-2012 and 2012-2013 Model-Based Prevalence Estimates (50 States and the District of Columbia). Rockville, MD: Substance Abuse and Mental Health Services
Administration, 2014.

10 Massachusetts Department of Public Health. (2011). Nonfatal opioid-related cases by city/town, MA residents, FY2009. Retrieved from http://www.mass.gov/eohhs/docs/dph/injury-surveillance/opioid-nf-related-cases-town-fy09.pdf

11 Massachusetts Department of Public Health. (2009, September). Opioids: Trends and current status in Massachusetts. Retrieved from http://media.masslive.com/breakingnews/other/opioid_trends_2009.pdf

12 Massachusetts Department of Public Health. (2014). Data Brief:  Fatal Opioid-related Overdoses among MA Residents. Retrieved from: http://www.mass.gov/eohhs/docs/dph/injury-surveillance/overdose/fatal-op...

13 Massachusetts Department of Public Health. (2012b, January). Opioid overdose prevention strategies in Massachusetts. Retrieved from http://www.mass.gov/eohhs/docs/dph/substance-abuse/opioid-overdose- prevention-strategies.pdf

14 National Institute on Drug Abuse. (2012). DrugFacts: Prescription and over-the-counter medications. Retrieved from http://www.drugabuse.gov/publications/drugfacts/prescription-over-counter-medications

15 Hertz, J. A., & Knight, J. R. (2006). Prescription drug misuse: A growing national problem. Adolescent Medicine Clinics, 17(3), 751–769. doi: 10.1016/j.admecli.2006.06.009

16 National Institute on Drug Abuse. (2011). Prescription drugs: Abuse and addiction. Opioids. Retrieved from http://www.drugabuse.gov/publications/research-reports/prescription-drugs/opioids

17 Cicero, T. J., Ellis, M. S., & Surratt, H. L. (2012). Effect of abuse-deterrent formulation of OxyContin. New England Journal of Medicine, 367(2), 187–189. doi: 10.1056/NEJMc1204141

18 Sporer, K. A. (1999). Acute heroin overdose. Annals of Internal Medicine, 130(7), 584–590.

20 O’Connell, M., Boat, T., & Warner, K. (Eds.). (2009). Preventing mental, emotional, and behavioral disorders among young people: Progress and possibilities. Washington, DC: National Research Council and Institute of Medicine, The National Academies Press.

21 Center for the Application of Prevention Technologies. (2012a). Consequences of opioid use. Unpublished manuscript. Developed under contract with the Substance Abuse and Mental Health Services Administration. Reference # HHSS277200800004C.

22 Manchikanti, L., & Singh, A. (2008). Therapeutic opioids: A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician, 11(2 Suppl), S63-–S88.

23 Hernandez, S. H., & Nelson, L. S. (2010). Prescription drug abuse: Insight into the epidemic. [Review]. Clinical Pharmacology and Therapeutics, 88(3), 307–317. doi: 10.1038/clpt.2010.154

24 Strassels, S. A. (2009). Economic burden of prescription opioid misuse and abuse. [Review]. Journal of Managed Care Pharmacy, 15(7), 556–562.

25 Upadhyay, J., Maleki, N., Potter, J., Elman, I., Rudrauf, D., Knudsen, J., . . . & Borsook, D. (2010). Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain, 133(Pt 7), 2098–2114. doi: 10.1093/brain/awq138

26 Center for the Application of Prevention Technologies. (2012b). Risk and protective factors associated with non- medical use of opioids: Literature review (2006–2011). Unpublished manuscript. Developed under contract with the Substance Abuse and Mental Health Services Administration. Reference # HHSS277200800004C.

27 Hernández, E. (2009). Cultural competency for anti-drug coalitions. Retrieved from http://glfhc.org/nc4hcwp/wp- content/uploads/2009/09/Cultural-Competency-for-Anti-Drug-Coalitions.pdf

28 Substance Abuse and Mental Health Services Administration’s Center for the Application of Prevention Technologies. (n.d.). Strategic Prevention Framework. Retrieved from http://captus.samhsa.gov/prevention- practice/strategic-prevention-framework

29 Johnson, K., Hays, C., Hayden, C., & Daley, C. (2004). Building capacity and sustainability prevention innovations: A sustainability planning model. Evaluation and Program Planning, 27, 135–149.

30 Community Anti-Drug Coalitions of America, & National Coalition Institute. (2010a). Assessment primer: Analyzing the community, identifying problems and setting goals. Retrieved from http://www.cadca.org/files/resources/Assessment-Primer-2010.pdf

31 Center for the Application of Prevention Technologies. (2012c). Strategies/interventions for reducing non-medical use of opioids: Literature review (2006–2011). Unpublished manuscript. Developed under contract with the Substance Abuse and Mental Health Services Administration. Reference # HHSS277200800004C.

32 Community Anti-Drug Coalitions of America, & National Coalition Institute. (2010b). Cultural competence primer: Incorporating cultural competence into your comprehensive plan. Retrieved from www.cadca.org/files/resources/Cultural_Competence-09-2010.pdf

33 Community Anti-Drug Coalitions of America, & National Coalition Institute. (2009). Evaluation primer: Setting the context for a community anti-drug coalition evaluation. Retrieved from www.cadca.org/files/resources/Evaluation-Primer-2011.pdf

34 Office of Minority Health. (2013b, April). National standards for CLAS in health and health care: A blueprint for advancing and sustaining CLAS policy and practice. Retrieved from https://www.thinkculturalhealth.hhs.gov/pdfs/EnhancedCLASStandardsBlueprint.pdf

35 Goode, T. D., & Jones, W. (2009). Linguistic competence. Retrieved from http://nccc.georgetown.edu/documents/Definition%20of%20Linguistic%20Competence.pdf

36 National Center for Cultural Competence. (n.d.). Conceptual frameworks/models, guiding values and principles. Retrieved from http://nccc.georgetown.edu/foundations/frameworks.html

37 Office of Minority Health. (2013a). National CLAS standards: Fact sheet. Retrieved from https://www.thinkculturalhealth.hhs.gov/pdfs/NationalCLASStandardsFactSheet.pdf